1983
DOI: 10.1016/0014-4827(83)90170-2
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and secretion of proteoglycans by cultured chondrocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

1984
1984
1995
1995

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…The inability of DMD cells to recover spreading ability to the same extent as normal cells may thus be a consequence of a greater delay in the reconstitution of the GERL secretory pathway compared with normal fibroblasts. The pleiotropic action of monensin could distinguish between normal and DMD cells in other ways [for example, ionic substitution in model and cell membranes (39) and microtubule organization (40)], but this does not seem probable. However, our observations on seeding efficiency after prolonged exposure to the ionophore suggest no damage to the biochemical mechanisms required for cell-substrate attachment.…”
Section: Discussionmentioning
confidence: 99%
“…The inability of DMD cells to recover spreading ability to the same extent as normal cells may thus be a consequence of a greater delay in the reconstitution of the GERL secretory pathway compared with normal fibroblasts. The pleiotropic action of monensin could distinguish between normal and DMD cells in other ways [for example, ionic substitution in model and cell membranes (39) and microtubule organization (40)], but this does not seem probable. However, our observations on seeding efficiency after prolonged exposure to the ionophore suggest no damage to the biochemical mechanisms required for cell-substrate attachment.…”
Section: Discussionmentioning
confidence: 99%
“…Monensin may inhibit the conversion of oligosaccharides from the high mannose type to the complex type (Ledger et al, 1983;Sai and Tanzer, 1984) and interrupt Golgi transport at a point where the oligosaccharide product has not yet acquired galac-tose, fucose, and sialic acid (Tartakoff, 1983a,b). In cultured chondrocytes, monensin causes an inhibition of sulfate incorporation into chondroitin sulfate (Mitchell and Hardingham, 1982;Nishimoto et al, 1982;Burditt et al, 1985) and blocks intracellular transport of proteoglycans (Kajiwara and Tanzer, 1982;Nishimoto et al, 1982;Madsen et al, 1983;Tartakoff, 1983a;Burditt et al, 1985). Effects on proteoglycan secretion and procollagen secretion vary a t different doses (Tajiri et al, 1980;Mitchell and Hardingham, 1982;Goldberg and Toole, 1984).…”
Section: Binding To the Rer And Nuclear Envelopementioning
confidence: 99%
“…Thus, it was shown that heparin stimulates the synthesis and changes the sulfation pattern of the heparan sulfate from endothelial cells [Nader et al, 19891 and selenate arrests the synthesis of this compound [Dietrich et al, 19881. Monensin, a monovalent ionophore, has been shown to alter the normal structure of the Golgi complex and appears to slow or to arrest intraGolgi transport as well as to inhibit trans-Golgi functions such as terminal N-glycosylation, protein processing, and the sulfation of proteoglycans [Farquhar, 1985;Griffiths et al, 1983;Ledger and Tanzer, 1984;Tartakoff, 1982,19831. The influence of monensin on chondroitin sulfate and dermatan sulfate proteoglycan biosynthesis has been studied in chondrocytes of different origins [Burditt et al, 1985;Tanzer, 1981, 1982;Madsen et al, 1983;Nishimot0 et al, 1982a,b;Tajiri et al, 19801, rat chondrosarcoma [Mitchell and Hardingham, 19821, human skin fibroblasts [Hoppe et al, 19851, human melanoma [Bumol and Reisfel, 1982;Bumol et al, 1984;Harper et al, 19861, and rat ovarian granulosa cells wanagishita and Hascall, 19851 where it was shown a marked decrease in the incorporation of sulfate into the glycosaminoglycan chains. This undersulfation for chondroitin sulfate proteoglycan was due to a decreased 6-sulfation of the N-acetylgalactosamine moiety [Kajiwara and Tanzer, 1981;Madsen et al, 1983;Nishimoto et al, 1982a,b;Tajiri et al, 19801, whereas for dermatan sulfate proteoglycan it was related to a decrease of the 4-sulfated disaccharide containing iduronic acid residues [Hoppe et al, 1985;Yanagishita and Hascall, 19851.…”
mentioning
confidence: 99%
“…The influence of monensin on chondroitin sulfate and dermatan sulfate proteoglycan biosynthesis has been studied in chondrocytes of different origins [Burditt et al, 1985;Tanzer, 1981, 1982;Madsen et al, 1983;Nishimot0 et al, 1982a,b;Tajiri et al, 19801, rat chondrosarcoma [Mitchell and Hardingham, 19821, human skin fibroblasts [Hoppe et al, 19851, human melanoma [Bumol and Reisfel, 1982;Bumol et al, 1984;Harper et al, 19861, and rat ovarian granulosa cells wanagishita and Hascall, 19851 where it was shown a marked decrease in the incorporation of sulfate into the glycosaminoglycan chains. This undersulfation for chondroitin sulfate proteoglycan was due to a decreased 6-sulfation of the N-acetylgalactosamine moiety [Kajiwara and Tanzer, 1981;Madsen et al, 1983;Nishimoto et al, 1982a,b;Tajiri et al, 19801, whereas for dermatan sulfate proteoglycan it was related to a decrease of the 4-sulfated disaccharide containing iduronic acid residues [Hoppe et al, 1985;Yanagishita and Hascall, 19851. These studies furnished important clues as to the location of the different biosynthetic steps of chondroitin sulfate and dermatan sulfate in the Golgi apparatus.…”
mentioning
confidence: 99%